A large number of the investigations of COVID-19 vaccines at first restricted their enrollment to members who didn’t have other medical conditions. After early investigations showed that the vaccines were safe in the more extensive population, individuals with HIV have started to partake in examinations. (4) Notwithstanding restricted information, accessible data proposes current WHO suggested COVID-19 antibodies (Pfizer/BioNtech, Oxford/AstraZeneca, Johnson&Johnson) …